Literature DB >> 17804018

Management of non-motor symptoms in advanced Parkinson disease.

Daniel D Truong1, Roongroj Bhidayasiri, Erik Wolters.   

Abstract

Progress in pharmacology has markedly improved the treatment of early Parkinson's disease. The management of advanced Parkinson's symptoms, however, remains a challenge. These symptoms are divided into motor and non-motor symptoms. Non-motor symptoms may appear early or late in the disease and sometimes even before the onset of the first motor symptoms confirming the diagnosis. The spectrum of non-motor symptoms encompasses autonomic dysfunctions, sleep disorders, mood disorders, impulse control disorders, cognitive dysfunction, dementia, paranoia and hallucinations. They are often less appreciated than motor symptoms but are important sources of disability for many PD patients. This review describes these non-motor symptoms and their managements.

Entities:  

Mesh:

Year:  2007        PMID: 17804018     DOI: 10.1016/j.jns.2007.08.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 2.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

3.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

4.  Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

Authors:  Yehonatan Sharabi; David S Goldstein
Journal:  J Neurol Sci       Date:  2011-07-16       Impact factor: 3.181

5.  Feasibility of clinical hypnosis for the treatment of Parkinson's disease: a case study.

Authors:  Gary Elkins; Jim Sliwinski; Juliette Bowers; Elmyra Encarnacion
Journal:  Int J Clin Exp Hypn       Date:  2013

6.  Extrastriatal dopaminergic circuits of the Basal Ganglia.

Authors:  Karen S Rommelfanger; Thomas Wichmann
Journal:  Front Neuroanat       Date:  2010-10-27       Impact factor: 3.856

Review 7.  Parkinson's disease-related disorders in the impulsive-compulsive spectrum.

Authors:  Eric Ch Wolters; Ysbrand D van der Werf; Odile A van den Heuvel
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

8.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 9.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

10.  Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

Authors:  Tultul Nayyar; Michael Bubser; Marcus C Ferguson; M Diana Neely; J Shawn Goodwin; Thomas J Montine; Ariel Y Deutch; Twum A Ansah
Journal:  Eur J Neurosci       Date:  2009-07       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.